Immune-cell switch flips the metabolic war between tumors and T cells in immunotherapy-resistant cancers
A new study shows that activating the lipid sensor PPARδ in immune cells rather than cancer cells flips the metabolic ...
A new study shows that activating the lipid sensor PPARδ in immune cells rather than cancer cells flips the metabolic ...
New research shows that high-dose vitamin C activates the JAK2-STAT1 pathway to drive macrophages toward an anti-tumor M1 state, enhancing ...
A new Nature Cancer study reveals that the kinase GSK3β in colorectal tumor cells drives fumarate accumulation that epigenetically reprograms ...
A new review in Cancer Cell International explains how metabolic reprogramming in colorectal cancer tumors suppresses anti-tumor immunity and how ...
New research identifies the enzyme CYP2S1 as a driver of immunosuppressive cell recruitment and poor chemoimmunotherapy response in esophageal squamous ...
A new Molecular Cancer review proposes immune-pressure redistribution as a unifying framework explaining why patients resist PD-1/PD-L1 blockade and how ...
New research shows that the BTK inhibitor ibrutinib activates the protease matriptase in malignant B cells, preserving surface CD19 and ...
In a discovery that may finally explain one of the most confounding paradoxes in cancer biology, researchers at the Salk ...
A Hidden RNA-Decay System May Be the Achilles’ Heel of Small-Cell Lung Cancer Small-cell lung cancer, one of the most ...
Irvine, Calif., Aug. 20, 2026 — Immunotherapy has changed the outlook for many people with advanced cancer by turning the ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine